NextBeam

NextBeam is a high-volume E-Beam contract irradiator/sterilizer with full R&D capabilities specializing in precise, efficient, and reliable electron beam sterilization for Medtech and Life Science customers. The company, founded in 2020, aims to deliver precise, reliable, and sustainable sterilization services, and has already brought its first facility online in the Midwest in August 2022. As a fully ISO 13485 / 9001 certified and FDA-registered entity processing medical products, NextBeam's state-of-the-art 10MeV facility is designed for large volumes of unique medical device products. Additionally, it serves clients in a variety of industries, including biotech, pharma, high-purity nutraceutical, laboratory test equipment, and clinical testing supply industries. Notably, the company's processes meet the highest-grade industry benchmarks for quality, and its extensive and fully-validated toolsets enable the qualification of new customer products in days—typically at least 10x faster than other sterilizers.

With its focus on serving critical industries and efficient operations, NextBeam presents an intriguing opportunity for potential investors seeking exposure to the manufacturing sector. While specific investment details are not currently available, the company's commitment to cutting-edge sterilization technology and its alignment with key regulatory standards position it as a compelling prospect for venture capital consideration. As NextBeam continues to expand its operations and solidify its presence in the market, it presents potential for noteworthy investment opportunities within the United States.